Effect of high-dose zinc supplementation with oral hypoglycemic agents on glycemic control and inflammation in type-2 diabetic nephropathy patients

Journal of Natural Science, Biology and Medicine

Volumn 4, Issue 2, 2013, Pages 336-340

  Khan, Mohd Idreesh ^a   Siddique, Kauser Usman ^b   Ashfaq, Fauzia ^a   Ali, Wahid ^b   Reddy, Himanshu D ^b   Mishra, Arvind ^b  

^a Department of Community Medicine ^*  (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Glycemic control; Inflammation; Microalbuminuria; Type 2 diabetes; Zinc sulphate

Indexed keywords

EID: 84884240365     PISSN: 09769668     EISSN: 22297707     Source Type: Journal    
DOI: 10.4103/0976-9668.117002     Document Type: Article

References (30)

1. Agarwal SK, Dash SC. Spectrum of renal diseases in Indian adults. J Assoc Physicians India 2000;48:594-600.
2. American Diabetes Association. Nephropathy in diabetes (Position Statement). Diabetes Care 2004;27:79-83.
3. Ladeia AM, Stefanelli E, Ladeia-Frota C, Moreira A, Hiltner A, Adan L. Association between elevated serum C-reactive protein and triglyceride levels in young subjects with type 1 diabetes. Diabetes Care 2006;29:424-6.
4. Scheid DC, McCarthy LH, Lawler FH, Hamm RM, Reilly KE. Screening for microalbuminuria to prevent nephropathy in patients with diabetes: A systematic review of the evidence. J Fam Pract 2001;50:661-8.
5. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The insulin resistance atherosclerosis study. Kidney Int 2000;58:1703-10.
6. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death. Diabetes 2002;51:1157-65.
7. Navarro JF, Mora C, Maca M, Garca J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 2003;42:53-61.
8. Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, et al. C-reactive protein and soluble vascular cell adhesion -1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arterioscler Thromb Vasc Biol 2002;22:593-8.
9. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 2001;59:260-9.
10. Wijesekara N, Chimienti F, Wheeler MB. Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes Metab 2009;11:202-14.
11. Hennig B, Meerarani P, Toborek M, McClain CJ. Antioxidant-like properties of zinc in activated endothelial cells. J Am Coll Nutr 1999;18:152-8.
12. Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH. Antioxidant effect of zinc in humans. Free Radic Biol Med 2004;37:1182-90.
13. Marjani A. Plasma lipid peroxidation, zinc and erythrocyte Cu-Zn superoxide dismutase enzyme activity in patients with type 2 diabetes mellitus in Gorgan city (south east of the Caspian Sea). Internet J Endocrinol 2005;2:1540-2606.
14. Lee JH, Lee HJ, Lee IK, Yoon JS. Zinc and copper status of middle- and old-aged woman in type 2 diabetes. Korean J Nutr 2005;38:56-66.
15. Yoon JS, Lee JH. A suggestion to improve zinc status of type 2 diabetic women: Relation among zinc, protein and phytate intake. J Korean Diet Assoc 2007;13:301-10.
16. Gunasekara P, Hettiarachchi M, Liyanage C, Lekamwasam S. Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes. Diabetes Metab Syndr Obes 2011;4:53-60.
17. Afkhami-Ardekani M, Karimi M, Mohammadi SM, Nourani F, Soheilykhah S. Comparison of the effects of sodium metavanadate and zinc sulfate supplementation on lipid and glucose in patients with type 2 diabetes. Iran J Diabetes Obes 2009;1:22-29.
18. Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson RA. Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 2003;22:316-21.
19. Partida-Hernandez G, Arreola F, Fenton B, Cabeza M, Roman-Ramos R, Revilla-Monsalve MC. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother 2006;60:161-8.
20. Ghayour-Mobarhan M, Taylor A, New SA, Lamb DJ, Ferns GA. Determinants of serum copper, zinc and selenium in healthy subjects. Ann Clin Biochem 2005;42:364-75.
21. Garber AJ, Karlsson FO. Treatment of dyslipidemia in diabetes. Endocrinol Metab Clin North Am 2001;30:991-1010.
22. Hennig B, Toborek M, McClain CJ. High-energy diets, fatty acids and endothelial cell function: Implication for atherosclerosis. J Am Coll Nutr 2001;20:91-105.
23. Bao B, Prasad AS, Beck FW, Fitzgerald JT, Snell D, Bao GW, et al. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: A potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 2010;91:1634-41.
24. Prasad AS, Beck FW, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, et al. Zinc supplementation decreases incidence of infections in the elderly: Effect of zinc in generation of cytokines and oxidative stress. Am J Clin Nutr 2007;85:837-44.
25. Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA. Obesity, peroxisome proliferators-activated receptor, and atherosclerosis in type 2 diabetes. Arterioscler Thromb Vasc Biol 2006;26:28-40.
26. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, et al. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 1999;274:32048-54.
27. Reiterer G, Toborek M, Hennig B. Peroxisome proliferator activated receptors alpha and gamma require zinc for their anti-inflammatory properties in porcine vascular endothelial cells. J Nutr 2004;134:1711-5.
28. Parham M, Amini M, Aminorroaya A, Heidarian E. Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: A double blind, randomized, placebo controlled, cross-over trial. Rev Diabet Stud 2008;5:102-9.
29. Farvid MS, Jailali M, Siassi F, Hosseini FM. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes. Diabetes Care 2005;28:2458-64.
30. Bonnefont-Rousselot D. The role of antioxidant micronutrientents in the prevention of diabetic complications. Treat Endocrinol 2004;3:41-52.